FDA Issues Complete Response Letter for Toripalimab
In a complete response letter, the FDA asked drug manufacturers Coherus and Junshi Biosciences for a quality process change that the companies say is readily addressable.
Source: medscape.com
Stay updated with breaking news from Jared Weis. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
In a complete response letter, the FDA asked drug manufacturers Coherus and Junshi Biosciences for a quality process change that the companies say is readily addressable.